Comparing blood thinners after brain aneurysm stent
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares two combinations of blood thinners to see which works better for preventing clots after a stent procedure to treat an unruptured brain aneurysm. It is for people who have a specific gene test result that shows they process medicines normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain aneurysm that hasn't ruptured and are scheduled for a stent procedure.
- You are between 20 and 70 years old.
- You have a normal CYP2C19 gene result (a test that shows how your body processes certain blood thinners).
- You are not allergic to any of the study medications (aspirin, clopidogrel, ticagrelor, or heparin).
- You do not have a history of major bleeding, heart disease, stroke, or other serious health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
This trial compares using a genetic test to choose between two anti-clot medications (clopidogrel and ticagrelor) versus the usual approach of giving clopidogrel alone. It aims to see if personalized treatment can better prevent strokes in people with narrowed brain arteries.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
Hear when a new Antiplatelet Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.